Pakistan · Delayed Price · Currency is PKR GlaxoSmithKline Pakistan Statistics
Total Valuation
PSX:GLAXO has a market cap or net worth of PKR 105.76 billion. The enterprise value is 97.68 billion.
| Market Cap | 105.76B |
| Enterprise Value | 97.68B |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | Sep 2, 2026 |
Share Statistics
PSX:GLAXO has 318.47 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 318.47M |
| Shares Outstanding | 318.47M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 6.42% |
| Float | 55.21M |
Valuation Ratios
The trailing PE ratio is 10.16 and the forward PE ratio is 9.51.
| PE Ratio | 10.16 |
| Forward PE | 9.51 |
| PS Ratio | 1.58 |
| PB Ratio | 3.07 |
| P/TBV Ratio | 3.16 |
| P/FCF Ratio | 16.54 |
| P/OCF Ratio | 12.04 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.27, with an EV/FCF ratio of 15.28.
| EV / Earnings | 9.38 |
| EV / Sales | 1.46 |
| EV / EBITDA | 5.27 |
| EV / EBIT | 5.72 |
| EV / FCF | 15.28 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.28 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.06 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 32.68% and return on invested capital (ROIC) is 38.08%.
| Return on Equity (ROE) | 32.68% |
| Return on Assets (ROA) | 21.22% |
| Return on Invested Capital (ROIC) | 38.08% |
| Return on Capital Employed (ROCE) | 47.09% |
| Weighted Average Cost of Capital (WACC) | 6.52% |
| Revenue Per Employee | 41.79M |
| Profits Per Employee | 6.48M |
| Employee Count | 1,606 |
| Asset Turnover | 1.33 |
| Inventory Turnover | 2.75 |
Taxes
In the past 12 months, PSX:GLAXO has paid 7.19 billion in taxes.
| Income Tax | 7.19B |
| Effective Tax Rate | 40.85% |
Stock Price Statistics
The stock price has decreased by -20.60% in the last 52 weeks. The beta is 0.42, so PSX:GLAXO's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -20.60% |
| 50-Day Moving Average | 355.31 |
| 200-Day Moving Average | 370.83 |
| Relative Strength Index (RSI) | 32.87 |
| Average Volume (20 Days) | 230,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PSX:GLAXO had revenue of PKR 67.12 billion and earned 10.41 billion in profits. Earnings per share was 32.69.
| Revenue | 67.12B |
| Gross Profit | 25.50B |
| Operating Income | 17.09B |
| Pretax Income | 17.60B |
| Net Income | 10.41B |
| EBITDA | 18.50B |
| EBIT | 17.09B |
| Earnings Per Share (EPS) | 32.69 |
Balance Sheet
The company has 8.43 billion in cash and 353.40 million in debt, with a net cash position of 8.07 billion or 25.35 per share.
| Cash & Cash Equivalents | 8.43B |
| Total Debt | 353.40M |
| Net Cash | 8.07B |
| Net Cash Per Share | 25.35 |
| Equity (Book Value) | 34.43B |
| Book Value Per Share | 108.20 |
| Working Capital | 20.86B |
Cash Flow
In the last 12 months, operating cash flow was 8.78 billion and capital expenditures -2.39 billion, giving a free cash flow of 6.39 billion.
| Operating Cash Flow | 8.78B |
| Capital Expenditures | -2.39B |
| Depreciation & Amortization | 1.41B |
| Net Borrowing | -64.77M |
| Free Cash Flow | 6.39B |
| FCF Per Share | 20.08 |
Margins
Gross margin is 38.00%, with operating and profit margins of 25.46% and 15.51%.
| Gross Margin | 38.00% |
| Operating Margin | 25.46% |
| Pretax Margin | 26.22% |
| Profit Margin | 15.51% |
| EBITDA Margin | 27.57% |
| EBIT Margin | 25.46% |
| FCF Margin | 9.53% |
Dividends & Yields
This stock pays an annual dividend of 19.00, which amounts to a dividend yield of 5.83%.
| Dividend Per Share | 19.00 |
| Dividend Yield | 5.83% |
| Dividend Growth (YoY) | 26.67% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 58.12% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 4.96% |
| Earnings Yield | 9.84% |
| FCF Yield | 6.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for PSX:GLAXO is 510.00, which is 56.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 510.00 |
| Price Target Difference | 56.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 7.46% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on April 18, 2014. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 18, 2014 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
PSX:GLAXO has an Altman Z-Score of 7.74 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.74 |
| Piotroski F-Score | 5 |